Table 6.
Logistic regression analysis of microvascular complications and associated risk factors
MALE | ||||
Variable | B | 95% Confidence Interval |
p- value | Odds Ratio(OR) |
Antiplatelet | −1.597 | 0.079 – 0.520 | 0.001* | 0.203 |
Lipid lowering | − 0.093 | 0.401 – 2.071 | 0.825 | 0.911 |
drug | 0.226 | 0.570 – 2.758 | 0.574 | 1.253 |
Smoking | −0.208 | 0.510 – 1.293 | 0.380 | 0.812 |
Alcohol | 0.027 | 0.475 – 2.379 | 0.945 | 1.028 |
WC(cm) | 0.017 | 0.435 – 2.380 | 0.968 | 1.017 |
SBP(mmHg) | 0.792 | 0.970 – 5.071 | 0.049* | 2.218 |
DBP(mmHg) | 0.214 | 0.343 – 1.515 | 0.562 | 0.783 |
FPG(mmol/l) | −0.514 | 0.135 – 1.197 | 0.278 | 0.598 |
2HPP(mmol/l) | −0.913 | 0.135 – 1.197 | 0.102 | 0.401 |
HBA1c (%) | −1.223 | 0.069 – 1.248 | 0.097 | 0.294 |
TC(mmol/l) | 0.404 | 0.413 – 5.444 | 0.539 | 1.498 |
LDL(mmol/l) | 0.797 | 0.289 – 1.459 | 0.296 | 0.792 |
HDL(mmol/l) | −0.527 | 0.225 – 1.517 | 0.284 | 0.591 |
TG(mmol/l) | ||||
FEMALE | ||||
Antiplatelet | −0.702 | 0.244 – 1.007 | 0.040* | 0.496 |
Lipid lowering | 0.112 | 0.582 – 2.151 | 0.736 | 1.119 |
drug | 0.257 | 0.162 – 3.695 | 0.747 | 0.773 |
Smoking | 0.102 | 0.738 – 1.662 | 0.623 | 1.107 |
Alcohol | 0.168 | 0.397 – 3.524 | 0.762 | 1.183 |
WC(cm) | 0.183 | 0.409 – 1.697 | 0.615 | 0.833 |
SBP(mmHg) | 0.963 | 1.211 – 5.664 | 0.014* | 2.619 |
DBP(mmHg) | 0.298 | 0.362 – 1.824 | 0.418 | 0.743 |
FPG(mmol/l) | 0.150 | 0.462 – 1.960 | 0.892 | 0.951 |
2HPP(mmol/l) | 0.527 | 0.271 – 1.285 | 0.184 | 0.591 |
HBA1c (%) | 0.050 | 0.400 – 2.767 | 0.918 | 1.052 |
TC(mmol/l) | 0.236 | 0.490 – 3.274 | 0.626 | 1.266 |
LDL(mmol/l) | 0.032 | 0.494 – 2.159 | 0.932 | 1.033 |
HDL(mmol/l) | −0.786 | 0.187 – 1.109 | 0.083 | 0.456 |
TG(mmol/l) |
HHT- history of hypertension, DDM- duration of diabetes, MDM- medication for diabetes, DHT- duration of hypertension
significant.